serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.758 Ocular Motility Disorders .
C10.292 Cranial Nerve Diseases .
C10.292.562 Ocular Motility Disorders .
C11 Eye Diseases .
C11.590 Ocular Motility Disorders .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.526 Hydrocarbons, Halogenated .
D02.455.526.728 Mustard Compounds .
D02.455.526.728.650 Nitrogen Mustard Compounds .
D02.455.526.728.650.730 Phosphoramide Mustards .
D02.455.526.728.650.730.243 Cyclophosphamide .
D02.705 Organophosphorus Compounds .
D02.705.672 Phosphoramides .
D02.705.672.500 Phosphoramide Mustards .
D02.705.672.500.243 Cyclophosphamide .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Cyclophosphamide .
B-518 .
Cyclophosphamide Anhydrous .
Cyclophosphamide Monohydrate .
Cyclophosphamide, (R)-Isomer .
Cyclophosphamide, (S)-Isomer .
Cyclophosphane .
Cytophosphan .
Cytophosphane .
Cytoxan .
Endoxan .
NSC-26271 .
Neosar .
Procytox .
Sendoxan .
Anhydrous, Cyclophosphamide .
B 518 .
B518 2751 .
Monohydrate, Cyclophosphamide .
NSC 26271 .
NSC26271 .
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. .
1.00
53446186
 
Ocular Motility Disorders .
Brown's Tendon Sheath Syndrome .
Convergence Excess .
Cyclophoria .
Deficiency, Smooth Pursuit .
Eye Motility Disorders .
Parinaud's Syndrome .
Paroxysmal Ocular Dyskinesia .
Pseudoophthalmoplegia .
Spasm of Conjugate Gaze .
Syndrome, Brown's Tendon Sheath .
Tendon Sheath Syndrome of Brown .
Conjugate Gaze Spasm .
Conjugate Gaze Spasms .
Convergence Excesses .
Convergence Insufficiencies .
Cyclophorias .
Deficiencies, Smooth Pursuit .
Deviation, Skew .
Deviations, Skew .
Dyskinesia, Paroxysmal Ocular .
Dyskinesias, Paroxysmal Ocular .
Excess, Convergence .
Eye Motility Disorder .
Eye Movement Disorder .
Gaze Spasms, Conjugate .
Insufficiencies, Convergence .
Insufficiency, Convergence .
Internuclear Ophthalmoplegias .
Ocular Dyskinesia, Paroxysmal .
Ocular Dyskinesias, Paroxysmal .
Ocular Motility Disorder .
Ophthalmoplegia, Internuclear .
Ophthalmoplegias, Internuclear .
Parinauds Syndrome .
Paroxysmal Ocular Dyskinesias .
Pseudoophthalmoplegias .
Pursuit Deficiencies, Smooth .
Pursuit Deficiency, Smooth .
Skew Deviations .
Smooth Pursuit Deficiencies .
Syndrome, Parinaud .
Syndrome, Parinaud's .
Ocular Torticollis .
Eye Movement Disorders .
Opsoclonus .
Brown Tendon Sheath Syndrome .
Convergence Insufficiency .
Internuclear Ophthalmoplegia .
Parinaud Syndrome .
Skew Deviation .
Smooth Pursuit Deficiency .
EYE MOTILITY DISORDERS .
Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240) .
0.66
873205